CD8A and neoplasm: Blood‐circulating CD8 T cells showed IFN‐γ and granzyme B (GrB) hyperfunction in response to anti‐CD3/28 stimulation, as well as impaired responses to ectopic tumour challenge and anti‐PD‐1/CTLA‐4 immunotherapy.